Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow margin | 26.2% | 24.6% | 32.1% | 23.7% | 34.2% | 30.8% | 14.7% | 27.6% | 26.7% | 31.6% | 30.8% | 26.6% | 26.3% | 27.1% | 25.4% | 19.3% | 27.7% | 36.7% | 25.9% | 8.2% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 13.7%, based on the financial report for Sep 29, 2024 (Q3 2024). The average annual Free Cash Flow margin for Pfizer Inc. have been 22.6% over the past three years, and 23.7% over the past five years.
As of today, Pfizer Inc.'s Free Cash Flow margin is 13.7%, which is lower than industry median of 19.1%. It indicates that Pfizer Inc.'s Free Cash Flow margin is Bad.